Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Liposomal formulations of anticancer drugs: selectivity and effectiveness
Ulrich Massing, Stefan Fuxius
Radiologie (Heidelberg, Germany)
|
June 26, 2025
[Malignant lymphoma]
Stefan Delorme, Stefan Fuxius, Marius Mayerhöfer
Anti-Cancer Drugs
|
October 24, 2002
Gemcitabine and interferon-alpha 2b in solid tumors: a phase I study in patients with advanced or metastatic non-small cell lung, ovarian, pancreatic or renal cancer
Stefan Fuxius, Klaus Mross, Kambiz Mansouri, et al.
Frontiers in Oncology
|
December 7, 2018
Patient Preferences Regarding Chemotherapy in Metastatic Breast Cancer-A Conjoint Analysis for Common Taxanes
Saskia Spaich, Johanna Kinder, Svetlana Hetjens, et al.
Clinical Nuclear Medicine
|
August 15, 2021
Two Tumors, One Target: Preliminary Experience With 90Y-FAPI Therapy in a Patient With Metastasized Breast and Colorectal Cancer
Hendrik Rathke, Stefan Fuxius, Frederik L Giesel, et al.
The Prostate
|
January 19, 2016
Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancer
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Anticancer Research
|
September 6, 2017
Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel
Jost VON Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Urologia Internationalis
|
July 13, 2017
Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Oncology Research and Treatment
|
October 5, 2018
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer
Jost von Hardenberg, Thomas S Worst, Niklas Westhoff, et al.
Oncology Research and Treatment
|
February 16, 2026
Vulnerability to infections and secondary immunodeficiencies in patients with non-Hodgkin's lymphomas starting anti-CD20 antibody containing therapies
Rudolf Weide, Johannes Mohm, Michael Gärtner, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Liposomal formulations of anticancer drugs: selectivity and effectiveness
Ulrich Massing, Stefan Fuxius
Radiologie (Heidelberg, Germany)
|
June 26, 2025
[Malignant lymphoma]
Stefan Delorme, Stefan Fuxius, Marius Mayerhöfer
Anti-Cancer Drugs
|
October 24, 2002
Gemcitabine and interferon-alpha 2b in solid tumors: a phase I study in patients with advanced or metastatic non-small cell lung, ovarian, pancreatic or renal cancer
Stefan Fuxius, Klaus Mross, Kambiz Mansouri, et al.
Frontiers in Oncology
|
December 7, 2018
Patient Preferences Regarding Chemotherapy in Metastatic Breast Cancer-A Conjoint Analysis for Common Taxanes
Saskia Spaich, Johanna Kinder, Svetlana Hetjens, et al.
Clinical Nuclear Medicine
|
August 15, 2021
Two Tumors, One Target: Preliminary Experience With 90Y-FAPI Therapy in a Patient With Metastasized Breast and Colorectal Cancer
Hendrik Rathke, Stefan Fuxius, Frederik L Giesel, et al.
The Prostate
|
January 19, 2016
Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancer
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Anticancer Research
|
September 6, 2017
Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel
Jost VON Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Urologia Internationalis
|
July 13, 2017
Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Oncology Research and Treatment
|
October 5, 2018
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer
Jost von Hardenberg, Thomas S Worst, Niklas Westhoff, et al.
Oncology Research and Treatment
|
February 16, 2026
Vulnerability to infections and secondary immunodeficiencies in patients with non-Hodgkin's lymphomas starting anti-CD20 antibody containing therapies
Rudolf Weide, Johannes Mohm, Michael Gärtner, et al.
Page
of 3